Effects of 21-aminosteroids on tumor necrosis factor-α in endotoxemia

被引：0
|
作者：
Zhang, HB [1 ]
Vincent, JL
机构：
[1] Univ Toronto, Mt Sinai Hosp, Div Resp Med, Toronto, ON M5G 1X5, Canada
[2] Free Univ Brussels, Erasme Univ Hosp, Dept Intens Care, B-1050 Brussels, Belgium
来源：
CRITICAL CARE MEDICINE | 2000年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3125 / 3125
页数：1
相关论文
共 50 条
  • [21] Divergent effects of tumor necrosis factor-α and lymphotoxin-α on lethal endotoxemia and infection with live Salmonella typhimurium in mice
    Dharmana, E
    Keuter, M
    Netea, MG
    Verschueren, ICMM
    Kullberg, BJ
    EUROPEAN CYTOKINE NETWORK, 2002, 13 (01) : 104 - 109
  • [22] The reduction of tumor necrosis factor-α release and tissue damage by pentobarbital in the experimental endotoxemia model
    Yang, Fwu Lin
    Li, Chi Han
    Hsu, Bang Gee
    Tsai, Nu-Man
    Lin, Shinn Zong
    Harn, Horng Jyh
    Chen, Hsing I.
    Liao, Kuang Wen
    Lee, Ru Ping
    SHOCK, 2007, 28 (03): : 309 - 316
  • [23] Tumor necrosis factor-α mediates hyperglycemia-augmented gut barrier dysfunction in endotoxemia
    Yajima, Satoshi
    Morisaki, Hiroshi
    Serita, Ryohei
    Suzuki, Takeshi
    Katori, Nobuyuki
    Asahara, Takashi
    Nomoto, Koji
    Kobayashi, Fujio
    Ishizaka, Akitoshi
    Takeda, Junzo
    CRITICAL CARE MEDICINE, 2009, 37 (03) : 1024 - 1030
  • [24] The activation of EGFR promotes myocardial tumor necrosis factor-α production and cardiac failure in endotoxemia
    Sun, Xuegang
    Liang, Jiani
    Yao, Xueqing
    Lu, Chunhua
    Zhong, Tianyu
    Hong, Xiaoyang
    Wang, Xiaofei
    Xu, Wenjuan
    Gu, Miaoning
    Tang, Jing
    ONCOTARGET, 2015, 6 (34) : 35478 - 35495
  • [25] Inhibition of tumor necrosis factor-α release in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G
    Lehmann, C
    Egerer, K
    Georgiew, A
    Weber, M
    Grune, T
    Kox, WJ
    CRITICAL CARE MEDICINE, 1999, 27 (06) : 1164 - 1167
  • [26] Tumor necrosis factor-α-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy
    Satoh, M
    Nakamura, M
    Saitoh, H
    Satoh, H
    Maesawa, C
    Segawa, N
    Tashiro, A
    Hiramori, K
    CIRCULATION, 1999, 99 (25) : 3260 - 3265
  • [27] The gene polymorphism of tumor necrosis factor-β, but not that of tumor necrosis factor-α, is associated with the prognosis of sarcoidosis
    Yamaguchi, E
    Itoh, A
    Hizawa, N
    Kawakami, Y
    CHEST, 2001, 119 (03) : 753 - 761
  • [28] Potentiation of Antitumor Effects of Cisplatin by Tumor Necrosis Factor-β
    G. M. Sysoeva
    V. A. Fadina
    N. A. Popova
    E. V. Nikitenko
    V. P. Nikolin
    S. I. Il'nitskaya
    V. I. Kaledin
    Bulletin of Experimental Biology and Medicine, 2001, 131 : 159 - 161
  • [29] Potentiation of antitumor effects of cisplatin by tumor necrosis factor-β
    Sysoeva, GM
    Fadina, VA
    Popova, NA
    Nikitenko, EV
    Nikolin, VP
    Il'nitskaya, SI
    Kaledin, VI
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 131 (02) : 159 - 161
  • [30] Tumor necrosis factor-α antagonists: Side effects and their management
    Dogra, Sunil
    Khullar, Geeti
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2013, 79 : S35 - S46
12345